Accumulating evidence suggests that peritoneal cytokine concentrations may predict anastomotic leak after colorectal surgery, but previous studies have been underpowered. We aimed to test this hypothesis by using a larger prospectively collected data set.
7 onwards. We also found that dscfDNA levels were independent of cholestasis in a separate recipient. On the other hand, dscfDNA levels were markedly elevated in a patient who developed an episode of organ rejection.
Conclusions:
In this pilot study, we demonstrated the robustness of our methodology for the detection and quantification of dscfDNA. Our methodology was readily-performed and results were attainable in 5.5 hours. Larger validation studies are required to confirm the diagnostic performance and clinical utility of dscfDNA, especially in the setting of other common posttransplant complications. 
THE IMMUNE INFILTRATE IN

Background:
Anal squamous cell carcinoma represents a relatively small proportion of lower gastrointestinal tumours. However, the incidence has more than doubled over the last four decades without an improvement in survival due to a lack of advancement in treatment options. While definitive chemoradiotherapy achieves a good outcome for many patients, a significant number suffer from persistent, relapsed or metastatic disease. Other than salvage surgery, there are at present no effective treatment options for this cohort who face a dismal prognosis.
Objective:
To determine the predictive power of the immune infiltrate in anal SCC and establish preclinical models to elucidate the effectiveness of immunotherapy as a new modality of treatment.
Methods:
Immunohistochemistry (IHC) and flow cytometry is being performed on a cohort of anal SCC patient specimens to examine the immune infiltrate for correlation with patient outcomes. In parallel, in vitro and in vivo preclinical anal SCC models have been established to enable the effectiveness of immunotherapies to be examined.
Results:
A pilot study examining the density of CD8+ immune cells in a cohort of 20 anal SCC patients has been undertaken, This has identified that 64% of patients (9/14) in the complete response cohort had a high TIL infiltrate compared with 0% (0/6) in the locoregional recurrence group, demonstrating a trend towards higher CD8 density correlating with disease free survival.
A human anal SCC explant in vitro model has been developed, which in conjunction with matched tumour infiltrating lymphocytes recreates the tumour-immune microenvironment to determine the modulatory effect of immunotherapy. A syngeneic mouse model of anal SCC has also been developed to act as an in vivo platform to examine the effect of immunotherapies
Conclusions:
The preliminary findings hold significant promise that the immune infiltrate of anal SCC may be useful as a predictor of patient response. The establishment of immunotherapy relevant in vitro and in vivo models will allow the first preclinical testing of immunotherapy in anal SCC. This research program will hopefully enhance the treatment options available to anal SCC patients, particularly for those with relapsed and metastatic disease. 1, 2, 3, 4 , GLEN R. GUERRA 1, 2, 3, 4 , ROSEMARY M. MILLEN 
DEVELOPING AN ORGANOID IMMUNE ASSAY FOR IMMUNOTHERAPY JOSEPH C. KONG
Background:
Current treatment algorithm for rectal cancer is neoadjuvant chemoradiotherapy followed by radical surgery. However 20-30% of patients do not respond to chemoradiotherapy, with no other therapeutic option left to increase tumour response rate. Promising emerging therapies employing immunotherapy by check-point inhibition and/or targeted-vaccine are now highly relevant. In view of the enthusiasm for immunotherapy, we recognise a gap in the capacity to explore these therapies, in particular utilising human primary cancer.
Therefore the aim is to develop a novel immune cytotoxic assay using a human-derived pre-clinical model to gain a better understanding of the biological efficacy of immunotherapy in neoadjuvant treatment of rectal cancer.
Methods:
This is a prospective observational study. Fresh rectal cancer biopsies were processed to generate rectal cancer organoids and tumourderived T infiltrating lymphocytes (TILs). TILs were Fluorescence-activated Cell Sorting (FACS) to determine the proportion of cytotoxic T cell. These are then co-cultured for 24 hours and organoid death is measured by fluorescence microscopy (Axiovert) using an apoptotic marker Caspase 3/7.
Results:
Six patients were recruited for this pilot study. An effector (TILs) to target (organoid) ratio of 10:1 showed complete organoid death in 12 hours, whereas a ratio of 1:1 appear to take up to 24 hours. Assays were extended for up to 5 days and irrespective of the effector to target ratio, a small proportion of organoids continue to survive.
Conclusion:
As a proof of concept, I have established that matched patient-derived TILs are capable of killing rectal cancer organoid cultures from the same patient tumour. The next step is to validate more extensively TIL function, organoid death and how to harness this model as a tool for high-throughput therapy screening. 
NOVEL METASTATIC MODELS OF HUMAN ESOPHAGEAL
Division of Cancer Research, Peter MacCallum Cancer Centre
Introduction:
Metastatic esophageal cancer has a poor prognosis with limited treatment options. The pathogenesis of this disease is poorly understood despite the high incidence of metachronous and de novo metastasis. This is partly due to the paucity of preclinical models available to study this disease process.
Methods and Results:
Here we report that FLO-1, and derivation of its isogenic companion FLO-1LM, as two spontaneously metastatic cell line models of human esophageal adenocarcinoma (EAC). We show that FLO-1 has undergone epithelial-mesenchymal transition and metastasizes following subcutaneous injection in mice. FLO-1LM, derived from a FLO-1 liver metastasis, has markedly enhanced proliferative, clonogenic, anti-apoptotic, invasive, immune-tolerant and metastatic potential. Importantly, genomewide RNAseq profiling revealed significant enrichment of metastasis-related pathways in FLO-1LM cells, many of which are also evident in patient samples. Moreover, CDH1, which encodes the adhesion molecule E-cadherin, was the most significantly downregulated gene in FLO-1LM compared to FLO-1. Consistent with this, repressed E-cadherin expression, which is commonly reported in EAC, is functionally associated with increased FLO-1 metastasis and independently predicts poor patient survival.
Conclusions:
Collectively, these findings highlight the biological importance of E-cadherin activity in the pathogenesis of metastatic EAC, and validates the utility of FLO-1 parental and FLO-1LM cells as preclinical models of metastasis in this disease.
THE USE OF POSITRON EMISSION TOMOGRAPHY IN THE DIAGNOSIS OF COLORECTAL CANCER: A SINGLE CENTRE STUDY DORUK SEYFI, CHATIKA PREMARATNE, CHUONG BUI AND WALID BARTO
Department of Colorectal Surgery, Nepean Hospital Department of Nuclear Medicine, Nepean Hospital
Introduction:
Colonoscopy is the gold standard in the evaluation of colorectal cancer (CRC). However, colonoscopy remains an invasive diagnostic tool requiring anaesthesia with a 1:1000 perforation risk. Positron emission tomography is established in staging of many malignancies. Integration with computed tomography (PET/CT) allows for metabolic evaluation of tissue with anatomical mapping. The diagnostic role of PET/CT has been recently considered since incidental colonic uptake has been documented. Our study hypothesis is that PET/CT is a sensitive/specific diagnostic tool in patients with CRC.
Methods:
Ethics approval was obtained. PowerChart and Provation programs were used to obtain reports from PET/CTs, colonoscopies and histopathology. Inclusion criteria: adults >18 years of age, patients who have undergone PET/CT of any kind within 6 months of colonoscopy and patients who have undergone colonoscopy within 6 months of any PET/CT. This was to assess patients with incidental uptake as well as metabolic characteristics of lesions. Patients were excluded if they were actively receiving therapy for malignancy or if the diagnostic studies were >6 months apart.
Results:
Data was collected retrospectively for a 12-month period. 261 patients had colonoscopy and PET/CT within 6 months. 206 were excluded for previous treatment. The remaining 55 patients' data were used for analysis. Reports for both colonoscopy and PET/CT were obtained with histopathological correlation. These results were cross-referenced to assess for true positive/negative and false positive/negative findings. This allowed derivation of sensitivity/specificity and an odds ratio to determine the likelihood PET/CT would demonstrate CRC. The dataset was adjusted for age and gender. The sensitivity and specificity of colonoscopy in the detection of CRC is 
Conclusion:
PET/CT is a sensitive and specific modality for the diagnosis of CRC when compared with colonoscopy. It is non-invasive and becoming increasingly available. 
COLD IN SITU PERFUSION PRIOR TO LIVER AND PANCREAS PROCUREMENT FOR TRANSPLANTATION -
Introduction:
In order to increase the potential usable organs from multiorgan donors various means of improving outcomes are being investigated. One particular focus is on how best to improve donor in situ cold perfusion. However, there is considerable discrepancy in the literature and guidelines regarding the ideal perfusion route, volume and solution(s) for deceased donor liver and pancreas procurement, including for islet cell isolation.
Methods:
Eligible studies were identified from the Embase, Medline and Cochrane databases (1980 to current). Meta-analyses were conducted for comparisons between dual and aortic perfusion, and to analyse the efficacy of histidine-tryptophan-ketoglutarate (HTK) and/or Celsior as alternatives to University of Wisconsin (UW) solution. Semi-quantitative analyses were conducted for graft survival, operative complications and islet function, stratified by perfusion fluid and techniques.
Results:
Forty-four articles and 19 article subsets were included in qualitative comparisons and meta-analyses, respectively, encompassing 959 pancreatic transplants, 105 islet cell isolations, and 3 562 liver transplants. Aortic in situ pancreas perfusion with HTK compared to UW resulted in a higher peak lipase (standardized mean difference [SMD] 0.47, 95% CI 0.23-0.71; p < 0.001) and graft pancreatitis rate (risk ratio [RR] 2.16, 95% CI 1.29-3.60; p = 0.003). Initial graft function, biochemical parameters, thrombotic graft loss rates and biliary complications in hepatic allografts were no different for livers perfused/preserved with UW, HTK or Celsior. Using semi-quantitative analyses, UW compared to HTK aortic perfusion yielded median one-year pancreas graft survivals of 90% and 81%, respectively. The corresponding survivals for dual-perfused livers were 83%, 80%, and 83% for UW, HTK and Celsior, respectively. Dual perfusion was not superior to aortic-only liver perfusion with respect to graft survival, biliary complications or graft function.
Conclusions:
UW aortic-perfusion is clearly superior to HTK perfusion in terms of short-term whole-organ pancreas graft outcomes, whilst longerterm and islet isolation results are less clear requiring larger cohort studies or trials. There is no significant difference between UW, HTK or Celsior for liver perfusion and preservation. Dual perfusion does not provide benefits over aortic-only flushing for liver procurement. 
EFFECT OF TRANS-VERSUS EXTRAPERITONAL COLOSTOMY
Introduction:
Parastomal hernia is a relatively common complication following abdominoperineal resection (APR) and up to a third of effected patients require corrective surgical treatment. The purpose of this study was to compare the occurrence of parastomal hernia in association with extraperitoneal and transperitoneal stomas following an APR.
Methods:
All patients who had an elective APR for cancer at Auckland City Hospital between 1989 to 2015 were included. Presence of parastomal hernia was determined by ultrasound or review of CT scans. Post-operative complications were graded according to the Clavien-Dindo classification.
Results:
Of 126 screened patients, 76 patients were included. Forty-six had transperitoneal and thirty had extraperitoneal colostomies. The groups had a similar distribution of age, gender and body mass index. Follow-up was longer in the transperitoneal group (69.12 versus 46.3 months, p = 0.01) but there was no difference in follow-up time between patients with and without hernias. Total time spent in theatre was longer for extraperitoneal colostomy (322 versus 245 minutes, p = 0.044). There were significantly more parastomal hernias in the transperitoneal group (20 versus 5, p = 0.014). BMI was significantly higher in those who developed parastomal hernia (29 kg/m 2 versus 24 kg/m 2 , p = 0.05). Serious (ClavienDindo ≥3a) post-operative complications occurred at a higher rate in the extraperitoneal group (p = 0.016), but only three involved the stoma.
Conclusion:
Parastomal hernias occurred more frequently in patients who underwent transperitoneal colostomy during APR. Although the extraperitoneal group had more Clavien-Dindo ≥3a post-operative complications, most events were not stoma-related. 
PATIENT DERIVED METASTATIC PROSTATE CANCER DEPOSITS FOR THE DEVELOPMENT OF ACTIONABLE PERSONALISED CELL LINES ANDRE JOSHI
Introduction & Objectives:
Prostate cancer is difficult to culture in vitro, as demonstrated by the limited number of cell lines readily available. This has hindered the progress in understanding tumour pathogenesis and the therapeutic response of prostate cancer. Alternative models such as Patient Derived Xenografts (PDXs) are expensive and limited by their inability to manipulate cells genetically. Recent development of novel organoid in vitro culture technology has led to the development of multiple new in vitro prostate cancer cell line models. We aim to apply this new culture technology in order to develop novel in vitro prostate cancer cell line models and propagate patient derived samples to allow drug testing and next generation sequencing as part of a precision medicine approach to prostate cancer.
Methods:
Patient derived metastatic tissue samples were collected as part of a larger clinical trial. These were digested in Type II Collagenase (Gibco) for 2 hours and seeded directly onto Collagen Type I coated plates in Prostate Culture Media. Samples were cultured in vitro for a minimum of 2 weeks prior to validation methods. PSA ELISA (GenWay Biotech) of conditioned media along with RT-qPCR comparison of various gene products of interest between cultured patient samples and established prostate cancer cell lines was performed. in vitro samples were subsequently utilised for therapeutic screening.
Results:
A total of 5 patient samples were available for culture with histologically proven metastatic prostate cancer. Tissue from a 67 year old male with biochemical recurrence of prostate cancer was successfully cultured for validation after 4 weeks. PSA ELISA of conditioned media was positive, with a value up to 30 ng/ml. RT-qPCR confirmed expression of Prostate specific genes PSA, AR, FKBP5 and TMPRSS. Next generation sequencing and in vitro therapeutic screening of generated cultures is ongoing.
Conclusions:
We have been able to successfully culture patient derived prostate cancer samples using novel organoid in vitro culture technology. This suggests the potential role of using patient derived biopsy samples as part of a precision medicine approach to prostate cancer. Organoid in vitro culture technology could provide a vital stepping stone towards precision medicine in the future, involving the rapid generation of in vitro models from a patient to allow therapeutic screening to guide treatment for an individual patient.
YTTRIUM-90 RADIOEMBOLIZATION FOR UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA: A SYSTEMATIC REVIEW AND POOLED ANALYSIS DANIEL YANG, WINY WIDJAJA, VINCENT LAM AND SIMON SO
Department of Upper Gastrointestinal and Hepatobiliary Surgery, Westmead Hospital; Department of Interventional Radiology, Westmead Hospital
Introduction:
Intrahepatic cholangiocarcinoma (ICC) is the malignant transformation of cholangiocytes within the hepatic bile ducts, and represents the second most common malignant primary liver tumour. Surgical resection is the only potentially curative treatment, however, ICCs are often latent in its early stages and therefore demonstrate low resectability rates by the time of diagnosis. Yttrium-90 microsphere radioembolization treatment has been increasingly reported as an alternative treatment option for unresectable ICC. The goal of this study is to systematically review the current literature on the treatment of unresectable ICCs with yttrium-90 radioembolization and explore the effectiveness of this treatment modality.
Methods:
A comprehensive literature search of electronic databases was conducted on MEDLINE, EMBASE, SCOPIUS and the Cochrane Library. Inclusion and exclusion criteria were applied. The primary outcomes compared were overall survival and radiological tumour response to yttium-90 radioembolization.
Results:
A total of 20 studies published between October 2009 and June 2016 were included for review. These were a combination of retrospective and prospective cohort studies. 542 total patients were included in the analysis, with the largest study containing 68 patients, while the smallest had only 9. Median overall survival ranged from 7 months to 22 months across the 20 studies. Analysis based on pooled data demonstrated a mean overall survival of 13.44 months and a weighted median overall survival of 11.5months. Of the 20 included studies, 10 provided date on tumour response, determined by radiological studies. These responses were categorized according to either RECIST, modified RECIST, PERCIST or EASL criteria. Following pooled analysis, complete response was seen in 2% of patients, partial response in 29%, stable disease in 37.5% and disease progression in 18.75%. Only 1 reported case of down staging to resection following partial response was identified.
Conclusion:
Yttrum-90 radioembolization may be an effective therapy that offers survival benefits in cases of unresectable ICC. While early data suggests yttrium-90 radioembolization offers survival outcomes comparable to systemic chemotherapy and other intra-arterial therapies, further randomized clinical trials are required to address the need for standardized optimal treatment of unresectable ICCs. 
GEOSPATIAL VARIABILITY OF BREAST CANCER ACCORDING
Introduction:
Breast cancer was the most common cancer in Australian women in 2016. The primary risk factor is age. The incidence of breast cancer rises with age until approximately 50 years, then plateaus and declines by 80 years. Australian data in 2013 showed 22.8% of new breast cancers occurred in women ≤50 years; 51.6% in women 50-69 years; and 25.5% in women aged ≥70 years.
Few studies have assessed the geographic variability of age-based cancer risk within local hospital catchment areas. Hence, this preliminary study attempts to apply a spatial approach to categorise the frequency of breast cancer based on age of diagnosis and location of residence within the Sydney Local Health District (SLHD). The results from this study aim to design targeted prevention campaigns for different population demographics, improve screening and encourage the development of local health policy.
Methods:
All patients presenting to RPAH with late stage breast cancer (Stage III/IV) between July 2005-March 2013 were retrospectively identified. Information regarding patient demographics, breast cancer detail and clinical outcomes were collected. Patients were stratified according to age groups that reflect current breast screening practice in Australia: <40 years, 40-49, 50-69, and ≥70. Spatial analysis was used to determine geographic variability in the relative-risk of breast cancer occurrence by postcodes in the SLHD. Data was cross-correlated with the SEIFA summary measure (Socioeconomic Indexes for Areas). Choropleth maps were generated per index.
Results:
A total of 5317 patients presented to RPAH with late stage breast cancer over the study period. 7.27% (n = 388) of patients were <40 years; 21.33% (n = 1138) were 40-49; 56.64% (n = 3021) were 50-69; and 14.75% (n = 787) were ≥70.
For the <40 age group, higher relative-risk occurs in eastern SLHD; 40-49 higher relative-risk occurs in the eastern and southeastern regions; 50-69 years higher relative-risk occurs in the eastern, northeastern and central regions and for ≥70 higher relative-risk occurs in the east-central region.
Conclusions:
This novel method of geospatial analysis shows discrepancies in breast cancer risk by age, indicating that breast cancer can be more effectively targeted in the SLHD. Given Australia's ageing population and high proportion of females, this topic represents a pertinent epidemiological focus for expansion from a pilot study to nationwide mapping.
DO EXPERTS PRACTICE WHAT THEY PREACH? A STUDY OF VARIABILITY IN EXPERT PERFORMACE OF TEMPORAL BONE SURGERY JUN ZHOU, SUDANTHI WIJEWICKREMA, IOANNA IOANNOU, BRIDGET COPSON AND STEPHEN O'LEARY
Department of Otolaryngology, University of Melbourne
Introduction:
Virtual reality (VR) simulation has gained popularity as a supplement to traditional methods of surgical training. Along with providing a risk-free environment for practice, using VR allows the collection of performance metrics which can be used to develop performance goals. In previous studies comparing registrars and expert surgeons, it has been shown that skill level can be predicted by assessing surgical technique and dissection quality. No previous study has investigated the variability in areas drilled between expert surgeons, for example the completeness of anatomical exposure of landmarks and the approach to critical regions.
Objective:
We investigate the variation of drilled regions of expert and trainee surgeons performing virtual temporal bone surgery to identify their compliance with standard drilling procedures.
Methods:
The study participants were seven expert and six trainee ENT surgeons, who were asked to perform the surgical preparations for cochlear implantation on a virtual temporal bone. The temporal bone was divided into six regions using a semi-automated approach. The drilled area in each region was compared between groups using a sign test. Similarity within groups was calculated as a ratio of voxels (3D points) drilled by at least 75% of surgeons and at least 25% of surgeons.
Results:
The sign test showed that there was a significant difference between groups when performing critical tasks such as drilling in the regions of the facial nerve (p < 0.001), the facial recess (p < 0.001), and the round window (p < 0.001). In these regions, experts practice more similar to each other compared to trainees. There was no significant difference between the two groups in the cortical mastoidectomy stage.
Conclusion:
The results indicate that expertise in temporal bone surgery is related to the areas drilled. Experts perform similarly in critical parts of the procedure, following standard guidelines, and do indeed practice what they preach. With regards to surgical education and performance assessment, the results suggest that greater weight should be placed on the metrics taken at critical regions of temporal bone surgery. 
DEFINING LOW ANTERIOR RESECTION SYNDROME
Background:
There is increasing awareness of the poor functional outcome many patients suffer after sphincter-preserving rectal resection, termed 'low anterior resection syndrome' (LARS). There is no consensus definition of LARS and varying instruments have been employed to measure functional outcome, complicating research into incidence, contributing factors, and potential therapies.
Aim:
To describe the instruments and outcome measures used in studies of post-low anterior resection bowel dysfunction and identify major themes used in the assessment of LARS.
Methods:
A systematic review of the literature was performed for studies published between 1986 and 2016. The instruments and outcome measures used to report post-low anterior resection bowel function were extracted and their frequency of use calculated.
Results:
The search revealed 128 eligible studies. These employed 18 instruments, over 30 symptoms, and follow-up time periods from 4 weeks to 14.6 years. The most frequent follow up period was 12 months (48%). The most frequently reported outcomes were incontinence (97%), stool frequency (80%), urgency (67%), evacuatory dysfunction (47%), gas-stool discrimination (34%), and a measure of quality of life (80%). Faecal incontinence scoring systems were used frequently. The LARS Score and the Bowel Function Instrument (BFI) were used in only 9 studies.
Conclusion:
LARS is common, but there is substantial variation in the reporting of post-low anterior resection functional outcomes. Most studies have focused on incontinence, omitting other symptoms that correlate with patient quality of life. To improve and standardize research into LARS, a consensus definition should be developed, and these findings should inform this goal.
REVASCULARISATION IN ACUTE MESENTERIC ISCHAEMIA: A SYSTEMATIC REVIEW OF PROGNOSTIC FACTORS FOR MORTALITY CATHERINE DOUST, CINDY WANG AND SARAH AITKEN
Concord Institute of Academic Surgery, Concord Hospital
Introduction:
Mesenteric vascular occlusion carries a poor prognosis. There is no consensus about the role of arterial revascularisation or preoperative factors predicting survival in acute mesenteric ischaemic (AMI). Furthermore, variability amongst the prognostic studies makes systematic review of these factors challenging. The Quality of Prognostic Studies (QUIPS) tool assesses the validity and risk of bias in prognostic factor studies. This study systematically reviews prognostic factors that predict mortality in patients who have undergone revascularisation procedures for AMI using the QUIPS tool to assess for study comparability.
Method:
A systematic search of MEDLINE, EMBASE and Cochrane was performed to identify publications from 2000-2015 on AMI. Studies were eligible for inclusion if they described revascularisation for AMI as a result of thromboembolic disease. Excluded were case reports, review articles, editorials and publications on mesenteric ischaemia from chronic disease, venous or non-occlusive causes. Eligible studies were assessed using the QUIPS criteria according to six areas: factors participation, attrition, prognostic factor measurement, confounding measurement and account, outcome measurement, and analysis and reporting. Prognostic factors identified by multivariate analysis were included in the systematic review. Metaanalysis was performed where study population and factor measurement were sufficiently similar to allow collation.
Result:
Seven cohort studies were included (1 prospective, 6 retrospective). Mortality at 30 days or in the preoperative period ranged between 22%-47%. Eleven positive prognostic factors were identified. There was significant variability across all studies with high risk of confounding bias. Most prognostic factors were examined in only one study or demonstrated conflicting significance. Meta-analysis showed increasing age was a significant prognostic factor for mortality (OR1.06, 95%CI 1.02-1.09 P < .001). In two studies, endovascular therapy conferred survival benefit over open revascularization.
Conclusion:
Perioperative mortality remains high for patients undergoing revascularization for AMI. Increasing age was the only significant prognostic factor found on meta-analysis. Further research into specific prognostic factors predicting mortality would assist in developing clinical decision-making tools for AMI.
EUS-FNA DIAGNOSTIC ACCURACY IN SUSPICIOUS PANCREATIC MASS; A SYSTEMATIC REVIEW AND META-ANALYSIS WITH PRELIMINARY RESULTS
WINY WIDJAJA, DANIEL YANG AND VINCENT LAM
Department of Hepatobillary and Gastrointestinal Surgery, Westmead Hospital
Introduction:
Recent literature shows promising results in the use of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) in aiding diagnosis of pancreatic cancer. The aim of the study is to systematically review the diagnostic value of EUS-FNA in patients who presents with clinical and/or radiological suspicion of pancreatic cancer.
Methods:
A systematic literature search was performed in Medline, Embase and Cochrane Library from 1946 to Aug 2016. Studies were selected according to inclusion and exclusion set priori; the reference of standard was either surgical histopathology or clinical follow up of at least more than 6 months. Studies which examined core biopsy were excluded. Data collected was used to construct 2 by 2 table. Statistical analysis of data is used to calculate pooled value for sensitivity and specificity of EUS-FNA. Sub-group analysis and meta-regression is calculated to assess heterogeneity of the included studies; the variables considered are study design, number of patients, study location and QUADAS score. Study quality was assessed according to the QUADAS tool.
Results:
A total of 20 studies were identified between 1996 to 2015 and a total of 3604 patients were included in the analysis. Ten studies were prospective and ten studies were retrospective. The pooled sensitivity of EUS-FNA in the diagnosis of pancreatic cancer is 0.92 (95% CI: 0.91-0.93) and the specificity is 0.96 (95%CI: 0.94-0.98). The positive likelihood ratio is 29.74 (95%CI: 17.76-49.81) and the negative likelihood ratio is 0.07 (95%CI:0.06-0.90). The diagnostic accuracy of EUS-FNA is 93%. The median follow up is 14 months. In these studies, no major associated complications was reported and the minor complications was <1%. The median QUADAS score is 12. Preliminary sub-group analysis showed that there is significant difference of diagnostic accuracy in prospective versus retrospective studies is 91% versus 95%, p < 0.05. Further heterogeneity and sub-group analysis is pending.
Conclusion:
EUS-FNA has shown to be a highly sensitive and specific test in the investigation of pancreatic mass. With further instrumental advancement future research should also evaluate the potential efficacy of EUS-FNB on diagnosis accuracy.
CITED EVIDENCE OF ABNORMAL INTRA-COLONIC PRESSURE PROFILES IN DIVERTICULAR DISEASE -A SYSTEMATIC REVIEW AND META-ANALYSIS
REBEKAH JAUNG
1 , JASON ROBERTSON 1 , GREG O'GRADY
Results:
Ten studies (published 1962-2005 ) met inclusion criteria. The studies followed a wide variety of protocols and all used low-resolution manometry (sensor spacing range 7.5-15 cm). Six studies compared intrasigmoid pressure, with 5/6 showing higher pressure in diverticulosis vs. controls, but only two reached statistical significance. Meta-analysis showed no difference in mean intra-sigmoid pressures between the diverticulosis group and controls (standardised mean difference 1.88 [−0.16, 3.92] ; 3 studies). Meta-analysis of duration of regular contractile activity also revealed no difference (2.20 [−1.03, 5.42]). The 'motility index' (mean amplitude x % activity duration) could be pooled as a weighted mean from three studies, and was higher with diverticulosis (183.8 vs 345.8).
Conclusion:
This systematic review of manometry data shows that evidence for abnormal sigmoid colon pressure in diverticulosis currently is weak. Existing studies utilised inconsistent methodology, showed heterogeneous results, and are of limited quality. Higher quality studies using modern manometric techniques are needed to clarify the role of colonic pressure in diverticulosis and DD.
ANTERIOR RESECTION SYNDROME -SHOULD WE BE TELLING OUR PATIENTS TO EXPECT MORE? DANETTE B. WRIGHT, KHENG-SEONG NG, AND MARC A. GLADMAN
Academic Colorectal Unit, Sydney Medical School, University of Sydney
Introduction:
Anterior resection syndrome (ARS) is the collection of poorly defined symptoms of bowel dysfunction that frequently occur following anterior resection of the rectum. Currently, surgeons counsel patients that these symptoms ultimately resolve with time. The aim of this study was to comprehensively evaluate long-term bowel function following anterior resection.
Methods:
A self-administered questionnaire was completed by consecutive patients who had undergone anterior resection between 2002-2012 and had participated in an earlier study. The questionnaire included subjective and objective measures of post-operative bowel function, assessing long-term satisfaction with bowel function and severity of rectal storage and evacuatory function.
Results:
Of the 279 eligible patients, 206 (mean age 71 yrs) participated (74%). The mean duration of follow-up was 7.8 (2.5) years. Approximately one-quarter (24.8%) had an ultra-low anastomosis (1-5 cm), 27.2% a low anastomosis (6-10 cm) and 48.5% were 11-15 cm from the anal verge. Overall, patients experienced a mean of 5.7 symptoms of evaucatory (ED) or storage (SD) dysfunction. Concominant ED and SD was present in 51%, ED only in 26.7% and SD only in 8.7% with the remaining 13.6% being asymptomatic. The mean Cleveland Clinic Constipation Score (Wexner) was 5.3/30. Wexner scores were greater in those with >10 yrs of follow-up compared to <5 yrs and 5-10 yrs (P = 0.026). The mean Vaizey Incontinence Score was 4.8/24. For each additional symptom of SD or ED experienced, the odds of being satisfied with long-term bowel function was significantly reduced by 25% (OR 0.74, ) and was independent of patient age at follow-up. The number of SD or ED symptoms did not differ between patients followed-up for <5, 5-10 or >10 yrs. Overall, one-quarter (24.7%) were dissatisfied with their long-term bowel function, although multivariate analyses did not identify any factors associated with long-term satisfaction.
Conclusions:
Bowel dysfunction is prevalent and persistent in the longterm following anterior resection and includes symptoms of both storage and evacuation dysfunction. Evacuation (+/− storage) dysfunction is more prevalent on long-term follow-up but is omitted from existing Anterior Resection Syndrome scoring systems. Importantly, patients should be counselled that bowel dysfunction is persistent (and possibly permanent) postoperatively. 
Introduction:
With a staggering prevalence of 8-13% in the community, faecal incontinence (FI) constitutes a substantial health and economic burden. Recent advances mean that patients no longer need to suffer from this debilitating disorder. However, access to specialist services and treatment is dependent on timely referral by primary healthcare providers. Therefore, the aim of this study was to evaluate the current knowledge, skills and barriers to specialist referral of patients with FI by healthcare practitioners in Australia.
Methods:
A prospective, nationwide, cross-sectional study of primary healthcare providers including GPs, nurses and physiotherapists, attending a health education seminar was performed using a self-administered questionnaire.
Results:
1276 of 2857 delegates (44.7%) participated, consisting mostly of GPs (n = 878;74.8%), with the remainder comprising nurses (n = 139;11.8%) and midwives (n = 130;11.1%). Participants were predominately female (n = 867;83.3%) & practiced mostly in metropolitan areas (n = 635;63.7%).
The prevalence of FI amongst primary healthcare seekers was accurately estimated by only 236 participants (19%). Most (n = 939;74%) reported that they would refer incontinent patients to a surgeon for further investigation and treatment, with the vast majority choosing one based on the recommendation of a colleague (n = 573;47%).
1130 participants (90%) judged their prior training and education in the management of FI to be 'minimal' or 'absent', with the vast majority (n = 1137; 91%) reporting a desire to receive further education. The majority reported their overall knowledge (n = 882;70%) & current skills in the screening (n = 821;65%) & management (n = 852;68%) of FI as poor/very poor. The most common barrier to the screening &/or treatment of FI was their own personal lack of skills in managing this condition & knowing where (n = 912; 73%) and whom (n = 1042; 84%) to refer patients would help facilitate patient management.
Conclusions:
There are barriers to the effective assessment & treatment of patients with FI in primary care & appropriate referral to specialist services, which predominantly reflects lack of confidence on account of suboptimal education/training of primary healthcare providers. Given the appetite for further knowledge, specialists have an important role to play in engaging & supporting primary healthcare colleagues to improve patient care.
PROGNOSTIC FACTORS INFLUENCING DISCHARGE FROM HOSPITAL AFTER MAJOR VASCULAR SURGERY SARAH AITKEN, DEBORAH RANDALL, FIONA BLYTH AND VASIKARAN NAGANATHAN
Institute of Academic Surgery, Concord Repatriation General Hospital, University of Sydney
Introduction:
Vascular surgery is high risk and adverse discharge outcomes are common. This study uses data-linkage to identify prognostic factors that influence discharge outcomes after major vascular surgery.
Methods:
Electronic medical records of patients undergoing major vascular surgery were identified from the statewide government administrative database including the admission records of all patients who had vascular surgery in NSW from 2010-2012. Major vascular surgery was defined as carotid, aortoiliac and peripheral arterial surgery as well as major amputation. Comorbidities were assessed using the Charlson Index. Cox proportional hazard ratios and survival analyses with multiregression modeling were used to identify prognostic factors for adverse discharge outcomes of death, discharge to nursing home or prolonged hospital length of stay.
Results:
11,966 patients had a major vascular operation during the study period (13,584 procedures). The median age at time of first surgery was 73 years old (range 18-102 years) and 30% (n = 3565) of patients were female. The majority of procedures were performed in public hospitals (n = 8461, 71%) with a third of patients requiring emergency surgery (n = 3667, 31%). Mean length of hospital stay was 4.5 days. 30% of patients required intensive care (ICU) after vascular surgery. Mean survival was 233 days after surgery. 30% of patients required nursing home placement within three years of major vascular surgery. Multivariate analysis showed age >80 years (HR 1.6, P < .0001), increased comorbidities (HR 3.2, P < .0001), emergency surgery (HR 2.4, P < .0001), residence in a nursing home prior to hospital admission (HR 7.4, P.002), transfer from other hospital (HR 2.02, P = .002), and >5 days in ICU (HR 2.3, P < .0001) were all associated with lower overall survival. Increasing age was not a significant prognostic factor for prolonged hospital admissions (>10 days) but emergency hospital admission and prolonged ICU admission were predictive. Discharge to a nursing home was predicted by increasing age and comorbidity.
Conclusions:
Patients with advanced age, preoperative nursing home residence and increased comorbidities independently have a higher rate of adverse discharge outcomes after major vascular surgery. Knowledge of these prognostic factors can assist in identification of patients at high risk of adverse discharge outcomes and aid with early discharge planning and patient-centred clinical decision-making. 
A NOVEL METHOD OF ANALYZING AND INITIATING
Introduction:
A myriad of risk factors have been established for breast cancer. Prevention among at-risk women remains an area where significant gains can be achieved. At a local level, the success of interventions aimed at breast cancer prevention have been challenged by their ability to successfully adapt to the risk profile of an area. 7% of premature deaths from breast cancer are purely from spatial inequality. Socioeconomic factors, especially disadvantage, have been shown to play an important role in the differential distribution of the disease.
This study aims to improve rates of cancer screening and outcomes by identifying sub-groups in a local health district that have increased risk of presenting with late-stage breast cancer (LSBC).
Methods:
All patients presenting to the Royal Prince Alfred Hospital (RPAH) between July 2005-March 2013 were identified. For each patient, data was collected on: sociodemographics (including country-ofbirth), geographical area of residence, socioeconomic characteristics of residential area and the clinical features and outcomes of the cancer. The data were analyzed to identify sub-groups at greatest risk of presenting with LSBC. Geospatial analyses were conducted to ascertain if LSBC clustered in geographical areas or was associated with area-level socioeconomic characteristics captured by the SEIFA(socioeconomic-indexes-forareas) index.
Results:
A total of 5317 patients presented with LSBC over the study period. They were mapped over 49 contiguous regions. Most (47.54%; n = 2536) were Australian-born, followed by Southern/Eastern Europe (12.80%; n = 683) and North-East Asia (8.61%; n = 459). Among patients presenting with LSBC, most (50.11%; n = 1151) were Australian-born, followed by Southern/Eastern Europeans (11.84%; n = 683). LBSC was associated with area-level socioeconomic disadvantage within some postcodes. Patients residing in the northeastern and western regions of the health district had a greater likelihood of presenting with LSBC (relative-risk of 1.51-2.25). These areas were also characterized by socioeconomic disadvantage when correlated with the SEIFA index.
Conclusions:
SHLD residents in socioeconomically-deprived areas, who are of Australian or Eastern/Southern European descent were more likely to present with LSBC. Focused interventions targeting this cohort are required. Further exploratory analyses should be conducted to test associations across other hospital catchment zones. 
ROLE OF STEREOTACTIC BODY RADIOTHERAPY IN UNRESECTABLE AND UNTRANSPLANTABLE
